CERO THERAPEUTICS HOLDINGS, INC. - 8-K Filing
Cero Therapeutics Holdings entered into an amended and restated promissory note with SRX Health Solutions for up to $1,413,600. The note includes a $750,000 tranche funded on May 28, 2026, and an additional $663,600 funded on June 23, 2026. It bears 10% annual interest, matures on May 28, 2027, and is convertible into common stock at a price of up to $0.05 per share or 80% of the average low trading prices over prior days. (Items: 1.01 Entry into a Material Definitive Agreement, 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, 3.02 Unregistered Sales of Equity Securities, 9.01 Financial Statements and Exhibits)
Tickers: $PBAXU